Jianlong Ke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jianlong Ke has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Huimin Xu
Acupuncture and Tuina School Chengdu University of Traditional Chinese Medicine Chengdu Sichuan China
1 shared publicationShaoquan Xiong
Department of Oncology Hospital of Chengdu University of Traditional Chinese Medicine Chengdu Sichuan China
1 shared publicationYingzhe Luo
Department of Oncology Hospital of Chengdu University of Traditional Chinese Medicine Chengdu Sichuan China
1 shared publication
Latest Publications
- 29 September 2025
- Published by Wiley in Comprehensive Physiology
- Vol. 15 (5) , e70056
Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Physical Fatigue Through the Perspective of Immunosenescence
Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating illness marked by persistent fatigue, yet its mechanisms remain unclear. Growing evidence implicates immunosenescence—the age‐related decline in immune function—in the onset and persistence of fatigue. Methods: This review synthesizes clinical and experimental data to examine how immunosenescence contributes to ME/CFS. We focus on chronic inflammation, senescent immune phenotypes, mitochondrial dysfunction, and neuroendocrine imbalance, with emphasis on maladaptive crosstalk among immune, muscular, neuroendocrine, and vascular systems. Results: Aging immune cells drive chronic inflammation that impairs mitochondrial ATP production and promotes muscle catabolism. Concurrently, HPA‐axis suppression and β 2 ‐adrenergic dysfunction amplify immune dysregulation and energy imbalance. Together, these processes illustrate how immunosenescence sustains pathological cross‐organ signaling underlying systemic fatigue. Conclusion: Immunosenescence provides a unifying framework linking immune, metabolic, and neuroendocrine dysfunction in ME/CFS. Recognizing cross‐organ communication highlights its clinical relevance, suggesting biomarkers such as cytokines and exhaustion markers, and supports integrated therapeutic strategies targeting immune and metabolic networks.
- 29 September 2025
- Published by Wiley in Comprehensive Physiology
- Vol. 15 (5) , e70056
Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Physical Fatigue Through the Perspective of Immunosenescence
Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating illness marked by persistent fatigue, yet its mechanisms remain unclear. Growing evidence implicates immunosenescence—the age‐related decline in immune function—in the onset and persistence of fatigue. Methods: This review synthesizes clinical and experimental data to examine how immunosenescence contributes to ME/CFS. We focus on chronic inflammation, senescent immune phenotypes, mitochondrial dysfunction, and neuroendocrine imbalance, with emphasis on maladaptive crosstalk among immune, muscular, neuroendocrine, and vascular systems. Results: Aging immune cells drive chronic inflammation that impairs mitochondrial ATP production and promotes muscle catabolism. Concurrently, HPA‐axis suppression and β 2 ‐adrenergic dysfunction amplify immune dysregulation and energy imbalance. Together, these processes illustrate how immunosenescence sustains pathological cross‐organ signaling underlying systemic fatigue. Conclusion: Immunosenescence provides a unifying framework linking immune, metabolic, and neuroendocrine dysfunction in ME/CFS. Recognizing cross‐organ communication highlights its clinical relevance, suggesting biomarkers such as cytokines and exhaustion markers, and supports integrated therapeutic strategies targeting immune and metabolic networks.